[{"data":1,"prerenderedAt":153},["ShallowReactive",2],{"drug-silver-sulfadiazine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":23,"regimens":36,"contraindications":54,"warnings":74,"renal":75,"monitoring":76,"interactions":77,"review":78,"examples":81,"atc":93,"iran":95,"links":119,"populations":138,"usApproval":148},"silver-sulfadiazine",1,{"fa":7,"en":8},"کرم سولفادیازین نقره","Silver sulfadiazine cream","dermatology",{"fa":11,"en":12},"ضدمیکروب موضعی سوختگی","Topical burn antimicrobial",[14],{"name":15,"market":16},"Silvadene","US",[18,19,20,21,22],"silvadene","SSD","سیلور سولفادیازین","سولفادیازین نقره","پماد سوختگی",[24],{"id":25,"form":26,"route":27,"label":28,"concentration":29,"markets":31,"refs":32},"cream-1","cream","topical","1% cream",{"amount":5,"unit":30,"perUnit":30},"application",[16],[33],{"source":34,"section":35},"fda-silver-sulfadiazine","How Supplied",[37],{"id":38,"disease":38,"label":39,"population":42,"type":46,"unit":30,"dose":47,"refs":48,"limits":51},"burns",{"fa":40,"en":41},"سوختگی — یک یا دو بار در روز (ضخامت حدود ۱٫۵ mm)","Burns — once or twice daily (about 1\u002F16 inch thick)",{"minAge":43},{"value":44,"unit":45},2,"month","fixed",{"perDose":5,"dosesPerDay":5},[49],{"source":34,"section":50},"Dosage and Administration",{"maxPerDay":44,"refs":52},[53],{"source":34,"section":50},[55,64],{"id":56,"severity":57,"text":58,"refs":61},"ci","block",{"fa":59,"en":60},"حساسیت به سیلور سولفادیازین.","Hypersensitivity to silver sulfadiazine.",[62],{"source":34,"section":63},"Contraindications",{"id":65,"severity":57,"rule":66,"text":68,"refs":71},"newborn",{"maxAge":67},{"value":44,"unit":45},{"fa":69,"en":70},"نوزاد زیر ۲ ماه و نارس: خطر کرن ایکتروس؛ همچنین بارداری نزدیک ترم.","Newborns under 2 months and premature infants: kernicterus risk; also pregnancy near term.",[72],{"source":34,"section":73},"Warnings",[],[],[],[],{"status":79,"reviewer":80,"date":80},"unverified",null,[82,87],{"regimen":38,"formulation":25,"input":83,"expect":86},{"ageYears":84,"weightKg":85},10,30,{"perDose":5},{"regimen":38,"formulation":25,"input":88,"expect":91},{"ageYears":89,"weightKg":90},0.05,4,{"status":92},"blocked",[94],"D06BA01",{"status":96,"forms":97,"refs":114},"registered",[98,102,106,110],{"code":99,"en":100,"fa":101},"01129","SILVER SULFADIAZINE 10MG\u002FG 30G CREAM","کرم نقره سولفادیازین ۱۰ میلی‌گرم \u002F گرم ۳۰ گرم",{"code":103,"en":104,"fa":105},"01128","SILVER SULFADIAZINE 10MG\u002FG 500G CREAM","کرم نقره سولفادیازین ۱۰ میلی‌گرم \u002F گرم ۵۰۰ گرم",{"code":107,"en":108,"fa":109},"01130","SILVER SULFADIAZINE 10MG\u002FG 50G CREAM","کرم نقره سولفادیازین ۱۰ میلی‌گرم \u002F گرم ۵۰ گرم",{"code":111,"en":112,"fa":113},"21719","SILVER SULFADIAZINE CREAM TOPICAL 1 % 500 g","کرم نقره سولفادیازین ۱ درصد ۵۰۰ گرم",[115],{"source":116,"section":117,"url":118},"darooyab-generic","G-516\u002FSilver-Sulphadiazine-Topical","https:\u002F\u002Fwww.darooyab.ir\u002FG-516\u002FSilver-Sulphadiazine-Topical",[120,124,128,132,135],{"kind":121,"url":122,"label":123},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=018810","NDA018810",{"kind":125,"url":126,"label":127},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=b4d6694f-2b0a-4d64-9e05-2fef6d8e60d9","FDA Silver sulfadiazine",{"kind":129,"url":130,"label":131},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682598.html","Silver Sulfadiazine",{"kind":133,"url":134,"label":94},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=D06BA01",{"kind":136,"url":118,"label":137},"darooyab","Silver-Sulphadiazine-Topical",{"pregnancy":139},{"level":140,"text":141,"quote":144,"refs":145},"contraindicated",{"fa":142,"en":143},"برچسب: در بارداری منع مصرف دارد.","Label: contraindicated in pregnancy.","Because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, USP 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.",[146],{"source":34,"section":147},"CONTRAINDICATIONS",{"kind":149,"refs":150,"id":123},"NDA",[151],{"source":34,"section":152},"SPL approval \u002F marketing category",1792191869233]